Multiple Myeloma

Trial Protocol ID
USOR 22244_IM048022

Investigator
Jose Méndoza, M.D.

A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)

Learn More

Trial Protocol ID
USOR 20285_IST-337

Investigator
Mohit Narang, M.D.

A phase II trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in combination with Selinexor for patients with newly diagnosed multiple myeloma
Learn More

Trial Protocol ID
BGB-11417-105

Investigator
Mohit Narang, M.D.

A Phase 1b/2 study of BGB-11417 in Monotherapy and in Various Combinations with Dexamethasone and Carfilzomib in Multiple Myeloma -- SPONSOR HOLD
Learn More

Trial Protocol ID
AZA-MDS-006

Investigator
Mohit Narang, M.D.

Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry
Learn More